Literature DB >> 15389519

Increased expression of geminin stimulates the growth of mammary epithelial cells and is a frequent event in human tumors.

Micaela Montanari1, Alma Boninsegna, Beatrice Faraglia, Claudio Coco, Antonio Giordano, Achille Cittadini, Alessandro Sgambato.   

Abstract

Geminin is a potent inhibitor of origin assembly and re-replication in multicellular eukaryotes and is a negative regulator of DNA replication during the cell cycle. Thus, it was proposed as an inhibitor of cell proliferation and as a potential tumor suppressor gene. However, the protein was found specifically expressed in proliferating lymphocytes and epithelial cells and up-regulated in several malignancies. Therefore, geminin is now regarded as an oncogene but its role in tumor development remains unknown. In this study, we evaluated by Western blot analysis the expression of geminin in a series of human cancer cell lines of various histogenetic origin and in a series of human primary colon, rectal, and breast cancers. Expression of geminin was variable in different cell lines and not related to the expression level of the corresponding mRNA. Moreover, geminin was expressed at higher level in 56% and 58% of colon and rectal cancers, respectively, compared with the corresponding adjacent normal mucosa. A high expression of geminin was also detected by immunohistochemistry in 60% of human primary breast cancers. We also transfected a full-length geminin cDNA in a human non-tumorigenic and a cancer breast cell lines and obtained derivatives expressing high levels of the protein. Geminin overexpression stimulated cell cycle progression and proliferation in both normal and cancer cells and increased the anchorage--independent growth of breast cancer cells. These results demonstrate that expression of geminin is frequently deregulated in tumor cells and might play an important role in the regulation of cell growth in both normal and malignant cells. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389519     DOI: 10.1002/jcp.20120

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  16 in total

1.  Geminin promotes an epithelial-to-mesenchymal transition in an embryonic stem cell model of gastrulation.

Authors:  Nicole Slawny; K Sue O'Shea
Journal:  Stem Cells Dev       Date:  2013-03-06       Impact factor: 3.272

2.  Geminin regulates neuronal differentiation by antagonizing Brg1 activity.

Authors:  Seongjin Seo; Anabel Herr; Jong-Won Lim; Genova A Richardson; Helena Richardson; Kristen L Kroll
Journal:  Genes Dev       Date:  2005-07-15       Impact factor: 11.361

3.  Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance.

Authors:  Kohei Shomori; Keisuke Nishihara; Takayuki Tamura; Shigeru Tatebe; Yasushi Horie; Kanae Nosaka; Tomohiro Haruki; Yuki Hamamoto; Tatsushi Shiomi; Motoki Nakabayashi; Hisao Ito
Journal:  Gastric Cancer       Date:  2010-09-05       Impact factor: 7.370

4.  Selective killing of cancer cells by suppression of geminin activity.

Authors:  Wenge Zhu; Melvin L Depamphilis
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

5.  Geminin overexpression induces mammary tumors via suppressing cytokinesis.

Authors:  Zannel Blanchard; Rohit Malik; Nicole Mullins; Christine Maric; Hugh Luk; David Horio; Brenda Hernandez; Jeffrey Killeen; Wael M Elshamy
Journal:  Oncotarget       Date:  2011-12

6.  Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer.

Authors:  Maurizio Di Bonito; Monica Cantile; Francesca Collina; Giosuè Scognamiglio; Margherita Cerrone; Elvira La Mantia; Antonio Barbato; Giuseppina Liguori; Gerardo Botti
Journal:  J Breast Cancer       Date:  2012-06-28       Impact factor: 3.588

7.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07

8.  Frequent amplification of CENPF, GMNN and CDK13 genes in hepatocellular carcinomas.

Authors:  Hye-Eun Kim; Dae-Ghon Kim; Kyung Jin Lee; Jang Geun Son; Min-Young Song; Young-Mi Park; Jae-Jung Kim; Sung-Won Cho; Sung-Gil Chi; Hyun Sub Cheong; Hyoung Doo Shin; Sang-Wook Lee; Jong-Keuk Lee
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

9.  Aurora-A controls pre-replicative complex assembly and DNA replication by stabilizing geminin in mitosis.

Authors:  Takaaki Tsunematsu; Yoshihiro Takihara; Naozumi Ishimaru; Michele Pagano; Takashi Takata; Yasusei Kudo
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 10.  The Non-Canonical Role of Aurora-A in DNA Replication.

Authors:  Takaaki Tsunematsu; Rieko Arakaki; Akiko Yamada; Naozumi Ishimaru; Yasusei Kudo
Journal:  Front Oncol       Date:  2015-08-25       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.